The Endocannabinoid System and the Brain

Posted: 9 Jan 2013

See all articles by Raphael Mechoulam

Raphael Mechoulam

Hebrew University of Jerusalem

Linda Parker

University of Guelph

Date Written: January 2013

Abstract

The psychoactive constituent in cannabis, Δ-tetrahydrocannabinol (THC), was isolated in the mid-1960s, but the cannabinoid receptors, CB1 and CB2, and the major endogenous cannabinoids (anandamide and 2-arachidonoyl glycerol) were identified only 20 to 25 years later. The cannabinoid system affects both central nervous system (CNS) and peripheral processes. In this review, we have tried to summarize research - with an emphasis on recent publications - on the actions of the endocannabinoid system on anxiety, depression, neurogenesis, reward, cognition, learning, and memory. The effects are at times biphasic - lower doses causing effects opposite to those seen at high doses. Recently, numerous endocannabinoid-like compounds have been identified in the brain. Only a few have been investigated for their CNS activity, and future investigations on their action may throw light on a wide spectrum of brain functions.

Suggested Citation

Mechoulam, Raphael and Parker, Linda, The Endocannabinoid System and the Brain (January 2013). Annual Review of Psychology, Vol. 64, pp. 21-47, 2013, Available at SSRN: https://ssrn.com/abstract=2198230 or http://dx.doi.org/10.1146/annurev-psych-113011-143739

Raphael Mechoulam (Contact Author)

Hebrew University of Jerusalem ( email )

Mount Scopus
Jerusalem, Jerusalem 91905
Israel

Linda Parker

University of Guelph ( email )

Guelph, Ontario
Canada

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
993
PlumX Metrics